Assessing the effectiveness of pharmacotherapy for obsessive-compulsive disorder

Lancet Psychiatry. 2016 Nov;3(11):e16. doi: 10.1016/S2215-0366(16)30324-8.

Authors

Jeremy C S Johnson¹, James G Scott², Naomi Jess³

Affiliations

¹ Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia. Electronic address: jeremy.johnson@health.qld.gov.au.
² Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia; The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia.
³ Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia.

PMID: 27794375
DOI: 10.1016/S2215-0366(16)30324-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Humans
Network Meta-Analysis
Obsessive-Compulsive Disorder*
Psychotropic Drugs
Selective Serotonin Reuptake Inhibitors

Substances

Psychotropic Drugs
Serotonin Uptake Inhibitors